Dermal Absorption Assessment of Chemicals: Principles, Testing Methods, and Regulatory Applications

Dermal absorption assessment quantifies how much of a chemical penetrates the skin and reaches systemic circulation, providing essential data for hazard characterization, exposure modeling, and regulatory compliance under frameworks such as REACH, pesticide, biocide, and cosmetic regulations. This article explains the scientific principles, OECD-aligned testing methods, key measurement parameters, and typical applications of in vitro and in vivo percutaneous absorption studies.

Technical Overview

Dermal absorption, also known as percutaneous absorption, is the process by which a chemical crosses the stratum corneum, diffuses through the viable epidermis and dermis, and enters the systemic circulation. Because the skin is the primary route of occupational and consumer exposure for many solids, liquids, mixtures, and formulated products, quantifying dermal uptake is a cornerstone of chemical risk assessment and toxicokinetic characterization.

The evaluation is typically performed according to OECD Test Guideline 428 (in vitro method) or OECD Test Guideline 427 (in vivo method), supported by OECD Guidance Document No. 28 for the conduct of skin absorption studies. The resulting data feed directly into regulatory frameworks such as REACH, the EU Biocidal Products Regulation, plant protection product authorization, and cosmetic safety evaluation under the SCCS Notes of Guidance.

A complete dermal absorption assessment distinguishes three fractions of the applied dose: the dislodgeable or wash-off fraction removed from the skin surface, the skin-retained fraction remaining in the stratum corneum and viable tissue, and the absorbed dose reaching the receptor fluid or systemic circulation. This mass-balance approach allows accredited third-party laboratories and regulators to derive a conservative, scientifically defensible absorption percentage for risk assessment purposes.

Testing Samples

Industrial Chemicals and Intermediates

Substances subject to REACH registration at tonnage bands requiring toxicokinetic information are evaluated both as neat material and in representative dilutions, in order to refine worker exposure assessments and route-specific hazard characterization.

Plant Protection Products and Biocides

Active substances, formulated concentrates, and typical field dilutions are tested to refine operator, worker, and bystander exposure estimates, following the dermal absorption guidance issued by EFSA for agrochemical risk assessment.

Cosmetic Ingredients and Consumer Products

Finished cosmetics, sunscreens, hair dyes, and rinse-off or leave-on products are assessed to support margin-of-safety calculations, ensuring that systemic exposure resulting from normal product use remains below health-based guidance values.

Pharmaceutical and Specialty Formulations

Transdermal delivery candidates, topical drug formulations, disinfectants, and veterinary products are characterized to evaluate delivery efficiency, bioavailability, and residual skin deposition.

Test Matrices and Dose Forms

Samples may be applied as neat liquids, powders, aqueous dilutions, solvent-based formulations, or simulated workplace mixtures. Finite doses are applied at realistic levels, commonly 1 to 10 mg/cm² for solids or up to 10 µL/cm² for liquids, reflecting actual human exposure scenarios.

Testing Items

Core parameters reported in a dermal absorption study include:

• Total dermal absorption expressed as a percentage of the applied dose, typically defined as receptor fluid content plus retained skin fraction
• Mass balance recovery, with an acceptance range commonly set at 85% to 115% of the applied dose
• Distribution profile across wash-off, skin surface, tape-strip fractions, viable skin, receptor fluid, and apparatus rinses
• Steady-state flux and cumulative absorbed amount versus time profiles
• Permeability coefficient for infinite-dose experiments
• Lag time and apparent diffusion characteristics
• Skin retention and stratum corneum deposition determined by tape stripping
• Dose-dependent and formulation-dependent absorption comparisons
• Permeation through protective materials such as glove membranes where required

Quantification typically relies on radiolabelled techniques using carbon-14 or tritium with liquid scintillation counting, or on sensitive LC-MS/MS and GC-MS methods for non-radiolabelled studies.

Testing Methods

In Vitro Diffusion Cell Method (OECD TG 428)

Excised skin membranes, preferably dermatomed human skin of approximately 200 to 500 micrometers or enzymatically separated epidermis, with pig ear skin accepted as a relevant surrogate, are mounted in static Franz-type or flow-through diffusion cells. The receptor fluid, typically physiological saline buffered with additives such as bovine serum albumin or polyethylene glycol, is maintained at 32 degrees Celsius to mimic skin surface temperature. The test substance is applied at one or more finite dose levels for an exposure period of 8 to 24 hours, followed by surface washing and tape stripping where relevant. Receptor fluid is sampled serially over 24 hours to construct absorption kinetics, and analysis of all compartments supports full mass balance. Membrane integrity is verified before dosing using transepidermal water loss, electrical resistance, or permeation of reference markers such as caffeine.

In Vivo Dermal Absorption Method (OECD TG 427)

For definitive in vivo assessment, a radiolabelled dose is applied to a clipped, protected application site on rat skin. Absorbed material is quantified through excreta, blood, exhaled air trapping for volatile substances, cage washes, and terminal tissue and carcass analysis. The application site skin is excised and fractionated into surface wash, tape strips, and remaining skin at scheduled time points. Such studies are conducted under Good Laboratory Practice with ethical review, and their use is justified only when in vitro data alone cannot answer the regulatory question, consistent with animal welfare principles.

QSAR, Read-Across, and Default Values

Where experimental testing is waived or used for prioritization, dermal absorption can be estimated from physicochemical properties such as molecular weight, octanol-water partition coefficient, and water solubility using recognized computational estimation tools, expert judgment, or conservative default assumptions. Regulatory guidance from ECHA and EFSA defines the conditions under which such refinements are acceptable in place of measured data.

Study Design and Data Interpretation

A robust protocol includes at least six valid replicates per dose group, two dose levels spanning realistic exposure, and a suitable exposure duration with post-exposure monitoring. For agrochemical risk assessment, the combined approach using in vitro human skin, in vivo rat data, and in vitro rat data is widely applied to derive a refined human absorption estimate that replaces conservative defaults. Interpretation may exclude skin-bound residues from the absorbed dose for highly lipophilic substances when scientifically justified, which illustrates why expert evaluation of the dataset is essential before the value is used in exposure calculations.

Applications

• REACH registration and chemical safety reports: derivation of dermal route derived no-effect levels and refinement of worker exposure assessments
• Pesticide and biocide authorization: refinement of operator and worker exposure estimates in product dossiers
• Cosmetic ingredient safety: margin of safety calculations for systemic toxicological endpoints
• Occupational health: assignment of skin notations, glove selection, and permeation testing of personal protective equipment
• Pharmaceutical development: screening of transdermal candidates and optimization of topical formulations
• Exposure reconstruction: quantitative support for incident investigation and epidemiological studies

Studies supporting regulatory submissions are generally performed by accredited third-party laboratories operating under Good Laboratory Practice, ensuring data quality, traceability, and acceptance by competent authorities worldwide.

FAQ

Which guidelines govern dermal absorption testing?

OECD TG 428 covers in vitro studies, OECD TG 427 covers in vivo studies, and OECD Guidance Document No. 28 provides harmonized performance and reporting criteria. Sector-specific guidance from EFSA, ECHA, and the SCCS further defines study interpretation for pesticides, industrial chemicals, and cosmetics, respectively.

Is human skin always required?

Excised human skin is the preferred membrane for human-relevant risk assessment, followed by pig skin as an accepted surrogate. Rat skin is generally more permeable and is used mainly for comparative purposes or as part of the combined data approach for agrochemicals.

How is the absorbed dose calculated?

The absorbed dose is generally the sum of the receptor fluid content and the fraction retained in the treated skin, expressed as a percentage of the applied dose. Recoveries between 85% and 115% demonstrate acceptable mass balance; poor recovery requires conservative assumptions or repetition of the study.

How long does a study take?

The laboratory exposure and sampling phases are short, typically 24 hours of monitoring, but a full study including method development, analytical validation, and reporting generally requires several weeks to a few months depending on radiolabel synthesis and analytical complexity.

Can experimental testing be waived?

Yes. Where dermal absorption can be conservatively covered by a 100% default assumption, a validated computational estimate, or read-across from structurally related substances with adequate data, experimental studies may be waived in line with animal welfare principles and applicable regulatory guidance.